Streptococcal superantigen, mitogenic factor, and pyrogenic exotoxin B expressed by streptococcus pyogenes: Structure and function

Preparative Biochemistry and Biotechnology

Volumn 27, Issue 2-3, 1997, Pages 143-172

  Musser, James M ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

STREPTOCOCCUS PYOGENES;

EID: 0031147637     PISSN: 10826068     EISSN: None     Source Type: Journal    
DOI: 10.1080/10826069708000074     Document Type: Review

References (142)

1. Agarwal BL. Rheumatic heart disease unabated in developing countries. Lancet 1981; 1:910-911.
2. Pichichero ME, Disney FA, Green JL, Francis AB, Marsocci SM, Lynd AM, Wood GC. Comparative reliability of clinical, culture, and antigen detection methods for the diagnosis of group A beta-hemolytic streptococcal tonsillopharyngitis. Pediatr Ann 1992; 21:798-805.
3. Fischetti VA. Streptococcal M protein: molecular design and biological behavior. Clin Microbiol Rev 1989; 2:285-314.
4. Fischetti VA, Bessen DE, Schneewind O, Hruby DE. Protection against streptococcal mucosal colonization. In: Hook M, Switalski, Eds. Microbial Adhesion and Invasion. New York: Springer-Verlag, 1992:137-147.
5. Seppala H, Nissinen A, Jarvinen H, Huovinen S, Henriksson T, Herva E, Holm SE, Jahkola M, Katila M-L, Klaukka T, Kontiainen S, Liimatainen O, Oinonen S, Passi-Metsomaa L, Huovinen P. Resistance to erythromycin in group A streptococci. N Engl J Med 1992; 326:292-297.
6. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 1991; 325:783-793.
7. Stevens DL. Streptococcal toxic-shock syndrome: spectrum of disease, pathogenesis, and new concepts in treatment. Emerg Infect Dis 1995; 1:69-78.
8. Beachey EH, Giampapa CS, Abraham SM. Adhesion receptor mediated attachment of pathogenic bacteria to mucosal surfaces. Am Rev Respir Dis 1988; 138:545-548.
9. Hasty DL, Ofek I, Courtney HS, Doyle RJ. Multiple adhesions of streptococci. Infect Immun 1992; 60:2147-2152.
10. Ellen RP, Gibbons RJ. M protein-associated adherence of Streptococcus pyogenes to epithelial surfaces: prerequisite for virulence. Infect Immun 1972; 5:826-830.
11. Wang J-R, Stinson MW. M protein mediates streptococcal adhesion to Hep-2 cells. Infect Immun 1994; 62:442-448.
12. Wang J-R, Stinson MW. Streptococcal M6 protein binds to fucose-containing glycoproteins on cultured human epithelial cells. Infect Immun 1994; 62:1268-1274.
13. Courtney HS, Bronze MS, Dale JB, Hasty DL. Analysis of the role of M24 protein in group A streptococcal adhesion and colonization by use of Ω-interposon mutagenesis. Infect Immun 1994; 62:4868-4873.
14. Caparon MG, Stephens DS, Olsen A, Scott JR. Role of M protein in adherence of group A streptococci. Infect Immun 1991; 59:1811-1817.
15. Boyle MDP. Bacterial Immunoglobulin Binding Proteins, Vol. 1 and 2. San Diego: Academic Press, 1990.
16. Beachey EH, Ofek I. Epithelial cell binding of group A streptococci by lipoteichoic acid on fimbriae denuded of M protein. J Exp Med 1976; 143:759-771.
17. Valentin-Weigand P, Grulich-Henn J, Chhatwal GS, Muller-Berghaus G, Blobel H, Preissner KT. Mediation of adherence of streptococci to human endothelial cells by complement S protein (vitronectin). Infect Immun 1988; 56:2851-2855.
18. Hanski E, Caparon M. Protein F, a fibronectin-binding protein, is an adhesion of the group A streptococcus Streptococcus pyogenes. Proc Natl Acad Sci USA 1992; 89:6172-6176.
19. Hanski E, Horwitz PA, Caparon MG. Expression of protein F, the fibronectin-binding protein of Streptococcus pyogenes JRS4, in heterologous streptococcal and enterococcal strains promotes their adherence to respiratory epithelial cells. Infect Immun 1992; 60:5119-5125.
20. Pancholi V, Fischetti VA. A major surface protein on group A streptococci is a glyceraldehyde-3-phosphate-dehydrogenase with multiple binding activity. J Exp Med 1992; 176:415-426.
21. Sela S, Aviv A, Tovi A, Burstein I, Caparon MG, Hanski E. Protein F: an adhesin of Streptococcus pyogenes binds fibronectin via two distinct domains. Mol Microbiol 1993; 10:1049-1055.
22. Talay SR, Valentin-Weigand P, Jerlstrom PG, Timmis KN, Chhatwal GS. Fibronectin-binding protein of Streptococcus pyogenes: sequence of binding domain involved in adherence of streptococci to epithelial cells. Infect Immun 1993; 60:3837-3844.
23. Courtney HS, Li Y, Dale JB, Hasty DL. Cloning, sequencing, and expression of a fibronectin/fibrinogen-binding protein from group A streptococci. Infect Immun 1994; 62:3937-3946.
24. Talay SR, Valentin-Weigand P, Timmis KN, Chhatwal GS. Domain structure and conserved epitopes of Sfb protein, the fibronectin-binding adhesin of Streptococcus pyogenes. Mol Microbiol 1994; 13:531-539.
25. Kreikemeyer B, Talay SR, Chhatwal GS. Characterization of a novel fibronectin-binding surface protein in group A streptococci. Mol Microbiol 1995; 137-145.
26. Rakonjac JV, Robbins JC, Fischetti VA. DNA sequence of the serum opacity factor of group A streptococci: identification of a fibronectin-binding repeat domain. Infect Immun 1995; 63:622-631.
27. Lancefield RC. Current knowledge of the type specific M protein antigens of group A streptococci. J Immunol 1962; 89:307-313.
28. Wessels MR, Moses AE, Goldberg JB, DiCesare TJ. Hyaluronic acid capsule is a virulence factor for mucoid group A streptococci. Proc Natl Acad Sci USA 1991; 88:8317-8321.
29. Wessels MR, Bronze MS. Critical role of the group A streptococcal capsule in pharyngeal colonization and infection in mice. Proc Natl Acad Sci USA 1994; 91:12238-12242.
30. Wessels MR, Goldberg JB, Moses AE, DiCesare TJ. Effects on virulence of mutations in a locus essential for hyaluronic acid capsule expression in group A streptococci. Infect Immun 1994; 62:433-441.
31. Horstmann RD, Sievertsen HJ, Knoblock J, Fischetti VA. Antiphagocytic activity of streptococcal M protein: selective binding of complement control protein factor H. Proc Natl Acad Sci USA 1988; 85:1657-1661.
32. Horstmann RD, Sievertsen HJ, Leippe M, Fischetti VA. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect Immun 1992; 60:5036-5041.
33. Fischetti VA, Horstmann RD, Pancholi V. Location of the complement factor H binding site on streptococcal M6 protein. Infect Immun 1995; 63:149-153.
34. Chen CC, Cleary PP. Complete nucleotide sequence of the streptococcal C5a peptidase gene of Streptococcus pyogenes. J Biol Chem 1990; 265:3161-3167.
35. Cleary PP, Prahbu U, Dale JB, Wexler DE, Handley J. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun 1992; 60:5219-5223.
36. Tillett WS, Garner RL. The fibrinolytic activity of hemolytic streptococci. J Exp Med 1933; 58:485-502.
37. Wang H, Lottenberg R, Boyle MDP. Analysis of plasmin(ogen) acquisition by clinical isolates of group A streptococci incubated in human plasma. J Infect Dis 1994; 169:143-169.
38. Wang H, Lottenberg R, Boyle MDP. A role for fibrinogen in the streptokinase-dependent acquisition of plasmin(ogen) by group A streptococci. J Infect Dis 1995; 171:85-92.
39. Caparon MG, Scott JR. Identification of a gene that regulates expression of M protein, the major virulence determinant of group A streptococci. Proc Natl Acad Sci USA 1987; 84:8677-8681.
40. Scott JR, Cleary P, Caparon MG, Kehoe M, Heden L, Musser JM, Hollingshead S, Podbielski A. New name for the positive regulator of the M protein of group A Streptococcus. Mol Microbiol 1995; 17:799.
41. Chen C, Bormann N, Cleary PP. VirR and Mry are homologous trans-acting regulators of M protein and C5a peptidase expression in group A streptococci. Mol Gen Genet 1993; 241:685-693.
42. Perez-Casal J, Caparon MG, Scott JR. Mry, a frans-acting positive regulator of the M protein gene of Streptococcus pyogenes with similarity to the receptor proteins of two-component regulatory systems. J Bacteriol 1991; 173:2617-2624.
43. Perez-Casal JF, Dillon HF, Husmann LK, Graham B, Scott JR. Virulence of two Streptococcus pyogenes strains (types Ml and M3) associated with toxic-shock-like syndrome depends on an intact mry-like gene. Infect Immun 1993; 61:5426-5430.
44. Podbielski AA, Flosdorff A, Weber-Heynemann J. The group A streptococcal virR49 gene controls expression of four structural vir regulon genes. Infect Immun 1995; 63:9-20.
45. Podbielski A, Peterson JA, Cleary P. Surface protein-CAT reporter fusions demonstrate differential gene expression in the vir regulon of Streptococcus pyogenes. Mol Microbiol 1992; 6:2253-2265.
46. Caparon MG, Geist RT, Perez-Casal J, Scott JR. Environmental regulation of virulence in group A streptococci: transcription of the gene encoding M protein is stimulated by carbon dioxide. J Bacteriol 1992; 174:5693-5701.
47. Okada N, Geist RT, Caparon MG. Positive transcriptional control of mry regulates virulence in the group A Streptococcus. Mol Microbiol 1993; 7:893-903.
48. Fogg GC, Gibson CM, Caparon MG. The identification of rofA, a positive-acting regulatory component of prtF expression: use of an μγδ-based shuttle mutagenesis strategy in Streptococcus pyogenes. Mol Microbiol 1994; 11:671-684.
49. McIver KS, Heath AS, Scott JR. Regulation of virulence by environmental signals in group A streptococci: influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. Infect Immun 1995; 63:4540-4542.
50. Kehoe MA, Miller L, Walker JA, Boulnois GJ. Nucleotide sequence of the streptolysin O (SLO) gene: structural homologies between SLO and other membrane-damaging, thiol-activated toxins. Infect Immun 1987; 55:3228-3232.
51. Berge A, Sjobring U. PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J Biol Chem 1993; 268:25417-25424.
52. Bohach GA, Fast DJ, Nelson RD, Schlievert PM. Staphylococcal and streptococcal pyrogenic toxins involved in toxic shock syndrome and related illnesses. Crit Rev Microbiol 1990; 17:251-272.
53. Tomai M, Kotb M, Majumdijar G, Beachey EH. Superantigenicity of streptococcal M protein. J Exp Med 1990; 172:359-362.
54. Tomai MA, Schlievert PM, Kotb M. Distinct T-cell receptor Vβ gene usage by human T lymphocytes stimulated with the streptococcal pyrogenic exotoxins and pep M5 proteins. Infect Immun 1992; 60:701-705.
55. Watanabe-Ohnishi R, Aelion J, LeGros L, Tomai MA, Sokurenko EV, Newton D, Takahara J, Irino S, Rashed S, Kotb M. Characterization of unique human TCR Vβ specificities for a family of streptococcal superantigens represented by rheumatogenic serotypes of M protein. J Immunol 1994; 152:2066-2073.
56. Mollick JA, Miller GG, Musser JM, Cook RG, Rich RR. Isolation and characterization of a novel streptococcal superantigen. Trans Assoc Am Phys 1992; 60:110-122.
57. Mollick JA, Miller GG, Musser JM, Cook RG, Grossman D, Rich RR. A novel superantigen isolated from pathogenic strains of Streptococcus pyogenes with aminoterminal homology to staphylococcal enterotoxins B and C. J Clin Invest 1993; 92:710-719.
58. Reda KB, Kapur V, Goela D, Lamphear JG, Musser JM, Rich RR. Phylogenetic distribution of streptococcal superantigen SSA allelic variants provides evidence for horizontal transfer of ssa within Streptococcus pyogenes. Infect Immun 1996 (in press).
59. Reda KB, Kapur V, Mollick JA, Lamphear JG, Musser JM, Rich RR. Molecular characterization and phylogenetic distribution of the streptococcal superantigen gene (ssa) from Streptococcus pyogenes. Infect Immun 1994; 62:1867-1874.
60. Yutsudo T, Murai H, Gonzalez J, Takao T, Shimonishi Y, Takeda Y, Igarashi H, Hinuma Y. A new type of mitogenic factor produced by Streptococcus pyogenes. FEBS Lett 1992; 308:30-34.
61. Norrby-Teglund A, Norgren M, Holm SE, Andersson U, Andersson J. Similar cytokine induction profiles of a novel streptococcal exotoxin, MF, and pyrogenic exotoxins A and B. Infect Immun 1994; 62:3731-3738.
62. Iwasaki M, Igarashi H, Hinuma Y, Yutsudo T. Cloning, characterization and overexpression of a Streptococcus pyogenes gene encoding a new type of mitogenic factor. FEBS Lett 1993; 331:187-192.
63. Yutsudo T, Okumura K, Iwasaki M, Hara A, Kamitani S, Minamide W, Igarashi H, Hinuma Y. The gene encoding a new mitogenic factor in a Streptococcus pyogenes strain is distributed only in group A streptococci. Infect Immun 1994; 62:4000-4004.
64. Norrby-Teglund A, Newton D, Kotb M, Holm SE, Norgren M. Superantigenic properties of the group A streptococcal exotoxin SpeF (MF). Infect Immun 1994; 62:5227-5233.
65. Tranter HS, Brehm RD. Production, purification and identification of the staphylococcal enterotoxins. Soc Appl Bacteriol Symp Ser 1990; 19:1095-1115.
66. Reynolds D, Tranter HS, Sage R, Hambleton P. Novel method for purification of staphylococcal enterotoxin A. Appl Environ Microbiol 1988; 54:1761-1765.
67. Marrack P, Kappler J. The staphylococcal enterotoxins and their relatives. Science 1990; 248:705-711.
68. Grossman D, Van M, Mollick JA, Highlander SK, Rich RR. Mutation of the disulfide loop in staphylococcal enterotoxin A: consequences for T cell recognition. J Immunol 1991; 147:3274-3281.
69. Kapur V, Reda KB, Li L-L, Ho L-J, Rich RR, Musser JM. Characterization and distribution of insertion sequence IS1239 in Streptococcus pyogenes. Gene 1994; 150:135-140.
70. Norrby-Teglund A, Pauksens K, Holm SE, Norgren M. Relation between low capacity of human sera to inhibit streptococcal mitogens and serious manifestations of disease. J Infect Dis 1994; 170:585-591.
71. Watanabe-Ohnishi R, Low DE, McGeer A, Stevens DL, Schleivert PM, Newton D, Schwartz B, Kreiswirth B, Ontario Streptococcal Study Project, Kotb M. Selective depletion of Vβ-bearing T cells in patients with severe invasive group A streptococcal infections and streptococcal toxic shock syndrome. J Infect Dis 1995; 171:74-84.
72. Watson, DW. Host-parasite factors in group A streptococcal infections: pyrogenic and other effects of immunologic distinct exotoxins related to scarlet fever toxins. J Exp Med 1960; 111:255-283.
73. Stock AH, Lynn RJ. Preparation and properties of partially purified erythrogenic toxin B of group A streptococci. J Immunol 1961; 86:561-566.
74. Cunningham CM, Barsumian EL, Watson DW. Further purification of group A streptococcal pyrogenic exotoxin and characterization of the purified toxin. Infect Immun 1976; 14:767-775.
75. Barsumian EL, Cunningham CM, Schlievert PM, Watson DW. Heterogeneity of group A streptococcal pyrogenic exotoxin type B. Infect Immun 1978; 20:512-518.
76. Barsumian EL, Schlievert PM, Watson DW. Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun 1978; 22:681-688.
77. Cunningham CM, Watson DW. Suppression of antibody response by group A streptococcal pyrogenic exotoxin and characterization of the cells involved. Infect Immun 1978; 19:470-476.
78. Knoll H, Petermann F, Kohler W. Mitogenic activity of erythrogenic toxins. II. Communication: determination of erythrogenic toxins in cultural supernatants of Streptococcus pyogenes. Zbl Bakt Hyg I Abt Orig A 1978; 240:466-473.
79. Schlievert PM, Schoettle DJ, Watson DW. Nonspecific T-lymphocyte mitogenesis by pyrogenic exotoxins from group A streptococci and Staphylococcus aureus. Infect Immun 1979; 25:1075-1077.
80. Tonew E, Gerlach D, Tonew M, Kohler W. Induction of immune interferon by streptococcal erythrogenic toxins A and B. Zbl Bakt Hyg I Abt Orig A 1982; 252:463-471.
81. Gerlach D, Knoll, Köhler W, Ozegowski JH, Hribalova V. Isolation and characterization of erythrogenic toxins. V. Communication: identity of erythrogenic toxin type B and streptococcal proteinase precursor. Zbl Bakt Hyg I Abt Orig A 1983; 255:221-233.
82. Bohach GA, Hauser AR, Schlievert PM. Cloning of the gene, speB, for streptococcal pyrogenic exotoxin type B in Escherichia coli. Infect Immun 1988; 56:1665-1667.
83. Knoll H, Holm SE, Gerlach D, Ozegowski J-H, Kohler W. Tissue cages for study of experimental streptococcal infection in rabbits. III. Influence of immunization with erythrogenic toxin type A (ET A) and its toxoid on subsequent infection with an ET A producing strain. Zbl Bakt Hyg A 1988; 269:366-376.
84. Abe J, Forrester J, Nakahara T, Lafferty JA, Kotzin BL, Leung DYM. Selective stimulation of human T cells with streptococcal erythrogenic toxins A and B. J Immunol 1991; 146:3747-3750.
85. Knoll H, Sramek J, Vrbova K, Gerlach D, Reichardt W, Kohler W. Scarlet fever and types of erythrogenic toxins produced by the infecting streptococcal strains. Zbl Bakt 1991; 276:94-106.
86. Leonard BAB, Lee PK, Jenkins MK, Schlievert PM. Cell and receptor requirements for streptococcal exotoxin T-cell mitogenicity. Infect Immun 1991; 59:1210-1214.
87. Imanishi K, Igarashi H, Uchiyama T. Relative abilities of distinct isotypes of human major histocompatibility complex class II molecules to bind streptococcal pyrogenic exotoxin types A and B. Infect Immun 1992; 60:5025-5029.
88. Ohara-Nemoto Y, Sasaki M, Kaneko M, Nemoto T, Ota M. Cysteine protease activity of streptococcal pyrogenic exotoxin B. Can J Microbiol 1994; 40:930-936.
89. Ogburn CA, Harris TN, Harris S. Extracellular antigens in steady-state cultures of the hemolytic streptococcus: production of proteinase at low pH. J Bacteriol 1958; 76:142-151.
90. Elliott SD. A proteolytic enzyme produced by group A streptococci with special reference to its effect on the type-specific M antigen. J Exp Med 1945; 81:573-592.
91. Elliott SD, Dole VP. An inactive precursor of streptococcal proteinase. J Exp Med 1947; 85:305-320.
92. Elliott SD. The crystallization and serological differentiation of a streptococcal proteinase and its precursor. J Exp Med 1950; 92:201-219.
93. Shedlovsky T, Elliott SD. An electrophoretic study of a streptococcal proteinase and its precursor. J Exp Med 1951; 94:363-372.
94. Liu TY, Neumann NP, Elliott SD, Moore S, Stein WH. Chemical properties of streptococcal proteinase and its zymogen. J Biol Chem 1963; 238:251-256.
95. Liu TY, Elliott SD. Streptococcal proteinase: the zymogen to enzyme transformation. J Biol Chem 1965; 240:1138-1142.
96. Liu TY, Stein WH, Moore S, Elliott SD. The sequence of amino acid residues around the sulfhydryl group at the active site of streptococcal proteinase. J Biol Chem 1965; 240:1143-1149.
97. Kortt AA, Wysocki JR, Liu TY. Primary structure of streptococcal proteinase. I. Isolation, composition, and amino acid sequences of the tryptic and chymotryptic peptides of cyanogen bromide fragments 1 to 4. J Biol Chem 1976; 251:1941-1947.
98. Tai JY, Liu TY. Primary structure of streptococcal proteinase. II. Isolation, composition, and amino acid sequences of the tryptic and chymotryptic peptides of cyanogen bromide fragment 5. J Biol Chem 1976; 251:1948-1954.
99. Tai JY, Kortt AA, Liu TY, Elliott SD. Primary structure of streptococcal proteinase. III. Isolation of cyanogen bromide peptides: complete covalent structure of the polypeptide chain. J Biol Chem 1976; 251:1955-1959.
100. Yonaha K, Elliott SD, Liu TY. Primary structure of zymogen of streptococcal proteinase. J Protein Chem 1982; 1:317-334.
101. Mycek MJ, Elliott SD, Fruton JS. The specificity of a crystalline streptococcal proteinase. J Biol Chem 1952; 197:637-640.
102. Gerwin BI, Stein WH, Moore S. On the specificity of streptococcal proteinase. J Biol Chem 1966; 241:3331-3339.
103. Liu TY. Demonstration of the presence of a histidine residue at the active site of streptococcal proteinase. J Biol Chem 1967; 242:4029-4032.
104. Robinson GW. Reaction of a specific tryptophan residue in streptococcal proteinase with 2-hydroxy-5-nitrobenzyl bromide. J Biol Chem 1970; 245:4832-4841.
105. Kortt AA, Liu TY. On the mechanism of action of streptococcal proteinase. I. Active-site titration. Biochemistry 1973; 12:320-327.
106. Liu TY, Nomura N, Jonsson EK, Wallace BG. Streptococcal proteinase-catalyzed hydrolysis of some ester and amide substrates. J Biol Chem 1969; 244:5745-5756.
107. Kortt AA, Liu TY. On the mechanism of action of streptococcal proteinase. II. Comparison of the kinetics of proteinase- and papain-catalyzed hydrolysis of N-acylamino acid esters. Biochemistry 1973; 12:328-337.
108. Hauser AR, Schlievert PM. Nucleotide sequence of the streptococcal pyrogenic exotoxin type B gene and relationship between the toxin and the streptococcal proteinase precursor. J Bacteriol 1990; 172:4536-4542.
109. Kapur V, Topouzis S, Majesky MW, Li L-L, Hamrick MR, Hamill RJ, Patti JM, Musser JM. A conserved Streptococcus pyogenes extracellular cysteine protease cleaves human fibronectin and degrades vitronectin. Microb Pathog 1993; 15:327-346.
110. Musser JM, Stockbauer K, Kapur V, Rudgers G. Substitution of cysteine-192 in a highly conserved Streptococcus pyogenes extracellular cysteine protease (interleukin 1β convertase) alters proteolytic activity and ablates zymogen processing. Infect Immun 1996; 64:1913-1917.
111. Schlievert PM, Bettin KM, Watson DW. Production of pyrogenic exotoxin by groups of streptococci: association with group A. J Infect Dis 1979; 140:676-681.
112. Stevens DL, Tanner MH, Winship J, Swarts R, Ries KM, Schlievert PM, Kaplan E. Severe group A streptococcal infections associated with a toxic shock-like syndrome and scarlet fever toxin A. N Engl J Med 1989; 321:1-7.
113. Talkington DF, Schwartz B, Black CM, Todd J, Elliott J, Breiman RF, Facklam RR. Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with clinical components of streptococcal toxic shock syndrome. Infect Immun 1993; 61:3369-3374.
114. Hauser AR, Stevens DL, Kaplan EL, Schlievert PM. Molecular analysis of pyrogenic exotoxins from Streptococcus pyogenes isolates associated with toxic shock-like syndrome. J Clin Microbiol 1991; 29:1562-1567.
115. Rothbard S, Todd EW. Production of proteinase by hemolytic streptococci in various clinical conditions. J Exp Med 1948; 87:283-294.
116. Kellner A, Robertson T. Myocardial necrosis produced in animals by means of crystalline streptococcal proteinase. J Exp Med 1954; 99:495-504.
117. Bjorck L, Akesson P, Bohus M, Trojnar J, Abrahamson M, Olafsson I, Grubb A. Bacterial growth blocked by a synthetic peptide based on the structure of a human proteinase inhibitor. Nature 1989; 337:385-386.
118. Wolf BB, Gibson CA, Kapur V, Hussaini IM, Musser JM, Gonias SL. Proteolytically active streptococcal pyrogenic exotoxin B cleaves monocytic cell urokinase receptor and releases an active fragment of the receptor from the cell surface. J Biol Chem 1994; 269:30682-30687.
119. Holm SE, Norrby A, Berghold A-M, Norgren M. Aspects of pathogenesis of serious group A streptococcal infections in Sweden, 1988-1989. J Infect Dis 1992; 166:31-37.
120. Kapur V, Majesky MW, Li L-L, Black RA, Musser JM. Cleavage of interleukin 1β (IL-1β) precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus pyogenes. Proc Natl Acad Sci USA 1993; 90:7676-7680.
121. Kapur V, Maffei JT, Greer RS, Li L-L, Adams GJ, Musser JM. Vaccination with streptococcal extracellular cysteine protease (interleukin-1β convertase) protects mice against challenge with heterologous group A streptococci. Microb Pathog 1994; 16:443-450.
122. Burns EH Jr, Marciel AM, Musser JM. Activation of a 66-kDa human endothelial cell matrix metalloprotease by streptococcus pyogenes extracellular cysteine protease. Infect Immun (in press).
123. Berge A, Björck L. Streptococcal cysteine proteinase releases biologically active fragments of streptococcal surface proteins. J Biol Chem 1995; 270:9862-9867.
124. Shanley TP, Schrier D, Kapur V, Kehoe M, Musser JM, Ward PA. Streptococcal cysteine protease augments lung injury induced by products of group A streptococci. Infect Immun 1996; 64:870-877.
125. Todd EW. A study of the inhibition of streptococcal proteinase by sera of normal and immune animals and of patients infected with group A hemolytic streptococci. J Exp Med 1947; 85:591-606.
126. Frobisher M Jr. Tissue-digesting enzyme (histase) of streptococci. J Exp Med 1926; 44:777-786.
127. Seegal BC, Seegal D. Lytic action of certain strains of hemolytic streptococci on fresh sterile kidney and other tissues. J Bacteriol 1936; 32:621-629.
128. Rotta J. Sur la question de la proteinase streptococcique. G Mal Infett 1957; 9:3-8.
129. Knoll H, Holm SE, Gerlach D, Kohler W. Tissue cages for study of experimental streptococcal infection in rabbits. I. Production of erythrogenic exotoxins in vivo. Immunobiology 1982; 162:128-140.
130. Knoll H, Holm SE, Gerlach D, Kuhnemund O, Kohler W. Tissue cages for study of experimental streptococcal infection in rabbits. II. Humoral and cell-mediated immune responses to erythrogenic toxins. Immunobiology 1985: 169:116-127.
131. 130a. Gubba S, Low D, Musser JM. unpublished data.
132. Musser JM, Hauser AR, Kim MH, Schlievert PM, Nelson K, Selander RK. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive disease: clonal diversity and pyrogenic exotoxin expression. Proc Natl Acad Sci USA 1991; 88:2668-2672.
133. Yu C-E, Ferretti JJ. Frequency of the erythrogenic toxin B and C genes (speB and speC) among clinical isolates of group A streptococci. Infect Immun 1991; 59:211-215.
134. Reichardt W, Muller-Alouf H, Elouf E, Kohler W. Erythrogenic toxins type A, B, and C (ETA, ETB, ETC): occurrence of the genes and exotoxin formation from clinical Streptococcus pyogenes strains associated with streptococcal toxic shock-like syndrome (TSLS). FEMS Microbiol Lett 1992; 100:313-322.
135. Tyler SD, Johnson WM, Huang JC, Ashton FE, Wang G, Low De, Rozee KR. Streptococcal erythrogenic toxin genes: detection by polymerase chain reaction and association with disease in strains isolated in Canada from 1940 to 1991. J Clin Microbiol 1992;30:3127-3131.
136. Demers B, Simor AE, Vellend H, Schlievert PM, Bryne S, Jamieson F, Walmsley S, Low DE. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin Infect Dis 1993; 16:792-800.
137. Musser JM, Kapur V, Szeto J, Pan X, Swanson DS, Martin DR. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: recent intercontinental spread of a subclone causing episodes of invasive disease. Infect Immun 1995; 63:994-1003.
138. Musser JM, Kapur V, Kanjilal S, Shah U, Musher DM, Barg NL, Johnston KH, Schlievert PM, Henrichsen J, Gerlach D, Rakita RM, Tanna A, Cookson BD, Huang JC. Geographic and temporal distribution and molecular characterization of two highly pathogenic clones of Streptococcus pyogenes expressing allelic variants of pyrogenic exotoxin A (scarlet fever toxin). J Infect Dis 1993; 167:337-346.
139. Braun MA, Gerlach D, Hartwig UF, Ozegowski J-H, Romagne F, Carrel S, Kohler W, Fleischer B. Stimulation of human T cells by streptococcal "superantigen" erythrogenic toxins (scarlet fever toxins). J Immunol 1993; 150:2457-2466.
140. Gerlach D, Reichardt W, Fleischer B, Schmidt K-H. Separation of mitogenic and pyrogenic activities from so-called erythrogenic toxin type B (streptococcal proteinase). Zentralbl Bakteriol 1994; 280:507-514.
141. Schmidt K-H, Gerlach D, Wollweber L, Reichardt W, Mann K, Ozegowski J-H, Fleischer. Mitogenicity of M5 protein extracted from Streptococcus pyogenes cells is due to streptococcal pyrogenic exotoxin C and mitogenic factor MF. Infect Immun 1995; 63:4569-4575.
142. Musser JM, Gray BM, Schlievert PM, Pichichero ME. Streptococcus pyogenes pharyngitis: characterization of strains by multilocus enzyme genotype, M and T protein serotype, and pyrogenic exotoxin gene probing. J Clin Microbiol 1992; 30:600-603.